Volume 12, Issue 2 (6-2024)                   JoMMID 2024, 12(2): 100-109 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tramboo M R, Farhana A, Zahoor D, Iqbal I, Mohuiddin Z. Comparative Analysis of SARS-CoV-2 Antibodies in Diabetic and Non-Diabetic Healthcare Workers Post-Infection and Vaccination. JoMMID 2024; 12 (2) :100-109
URL: http://jommid.pasteur.ac.ir/article-1-606-en.html
Comparative Analysis of SARS-CoV-2 Antibodies in Diabetic and Non-Diabetic Healthcare Workers Post-Infection and Vaccination
Mariya Rouf Tramboo * , Anjum Farhana , Danish Zahoor , Ilhaam Iqbal , Zahoor Mohuiddin
Department of Microbiology, Government Medical College, Srinagar, Jammu and Kashmir, India
Abstract:   (280 Views)
Introduction: The COVID-19 pandemic has significantly impacted global health, and vaccines have been crucial in mitigating severe outcomes. However, the effect of type 2 diabetes on vaccine-induced immune responses is not fully understood. This study aims to analyze SARS-CoV-2 antibody levels in individuals with type 2 diabetes and compare them to individuals without diabetes to elucidate the complex interactions between diabetes and immune responses. Methods: At GMC Srinagar, India, a study involving 299 healthcare workers reviewed their vaccination status, SARS-CoV-2 infection history, and diabetes status. Blood samples were analyzed for HbA1c and IgG antibodies using ELISA and chemiluminescence assays. Descriptive and inferential statistics were used to analyze demographic data and compare groups. Results: More than two-thirds of the participants had prior COVID-19 infections, and vaccination rates were high. Diabetes significantly impacted antibody levels, with diabetic individuals showing lower IgG titers compared to non-diabetic individuals. Age and gender also influenced antibody levels: individuals aged 41-50 and 51-60 had higher anti-S antibody titers than younger age groups (t-test = 52.603, df = 15, P < 0.001). Males exhibited higher anti-S antibody titers compared to females (t-test = 7.483, df = 5, P = 0.007). Booster doses of the vaccine significantly enhanced antibody responses. Conclusion: This study highlights the impact of diabetes, age, gender, and vaccination history on SARS-CoV-2 antibody levels in healthcare workers. Diabetic individuals had lower antibody titers, while age and gender differences also affected antibody responses. These findings suggest the need for personalized vaccination strategies, especially for diabetic healthcare workers, to optimize COVID-19 prevention and ensure effective immunity.
 
Keywords: COVID-19, SARS-CoV-2 antibodies, Type 2 diabetes, Healthcare workers, Vaccine Efficacy, Antibody titers
Full-Text [PDF 885 kb]   (60 Downloads)    
Type of Study: Original article | Subject: Infectious diseases and public health
Received: 2023/10/3 | Accepted: 2024/09/20 | Published: 2024/09/18
References
1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard [Internet]. 2023 [cited 12 June 2023]. Available from: https://covid19.who.int/
2. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020; 395 (10242): 1973-87. [DOI:10.1016/S0140-6736(20)31142-9]
3. Forni G, Mantovani A. Vaccines and neutralizing monoclonal antibodies for COVID-19. N Engl J Med. 2022; 387 (7): 575-86.
4. Kaur SP, Gupta V. COVID-19 vaccine: a comprehensive status report. Virus Res. 2020; 288: 198114. [DOI:10.1016/j.virusres.2020.198114]
5. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020; 383: 2603-15. [DOI:10.1056/NEJMoa2034577]
6. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021; 384: 403-16. [DOI:10.1056/NEJMoa2035389]
7. Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020; 586: 594-9. [DOI:10.1038/s41586-020-2814-7]
8. Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, et al. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2021; 27: 270-8. [DOI:10.1038/s41591-020-01194-5]
9. Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021; 27: 1205-11. [DOI:10.1038/s41591-021-01377-8]
10. Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev. 2020; 16 (5): 442-9. [DOI:10.2174/1573399815666191024085838]
11. Onyemelukwe OU, Mamza AA, Suleiman YK, lyanda MA, Bello-Ovosi B, Bansi KI, et al. Prevalence of Pre-Diabetes, Diabetes and Associated Cardiovascular Risk Amongst Healthcare Workers in Ahmadu Bello University Teaching Hospital (ABUTH), Zaria using Glycated Haemoglobin. West Afr J Med. 2020; 37 (2): 91-9.
12. Ramli NS, Fauzi MFM, Moktar NMA, Hajib N, Nawi AM. Prevalence, characteristics, and predictors of healthcare workers with COVID-19 infection in an urban district in Malaysia. Pan Afr Med J. 2022; 41: 243. [DOI:10.11604/pamj.2022.41.243.33300]
13. Carlsson S, Andersson T, Talbäck M, Feychting M. Incidence and prevalence of type 2 diabetes by occupation: results from all Swedish employees. Diabetologia. 2020; 63 (1): 95-103. [DOI:10.1007/s00125-019-04997-5]
14. Cuschieri S, Grech S. COVID-19 and diabetes: The why, the what and the how. J Diabetes Complications. 2020; 34 (9): 107637. [DOI:10.1016/j.jdiacomp.2020.107637]
15. Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci. 2008; 13: 1227-39 [DOI:10.2741/2757]
16. Ishaq SE, Abdulqadir SZ, Khudhur ZO, Omar SA, Qadir MK, Awla HK, et al. Comparative study of SARS-CoV-2 antibody titers between male and female COVID-19 patients living in Kurdistan region of Iraq. Gene Rep. 2021; 25: 101409. [DOI:10.1016/j.genrep.2021.101409]
17. Ciarambino T, Para O, Giordano M. Immune system and COVID-19 by sex differences and age. Womens Health (Lond). 2021; 17: 17455065211022262. [DOI:10.1177/17455065211022262]
18. Ysrraelit MC, Correale J. Impact of sex hormones on immune function and multiple sclerosis development. Immunology. 2019; 156 (1): 9-22. [DOI:10.1111/imm.13004]
19. Fink AL, Klein SL. The evolution of greater humoral immunity in females than males: implications for vaccine efficacy. Curr Opin Physiol. 2018; 6: 16-20. [DOI:10.1016/j.cophys.2018.03.010]
20. Migliore L, Nicolì V, Stoccoro A. Gender Specific Differences in Disease Susceptibility: The Role of Epigenetics. Biomedicines. 2021; 9 (6): 652. [DOI:10.3390/biomedicines9060652]
21. Rehman S, Ravinayagam V, Nahvi I, Aldossary H, Al-Shammari M, Amiri MSA, et al. Immunity, Sex Hormones, and Environmental Factors as Determinants of COVID-19 Disparity in Women. Front Immunol. 2021; 12: 680845. [DOI:10.3389/fimmu.2021.680845]
22. Sciarra F, Campolo F, Franceschini E, Carlomagno F, Venneri MA. Gender-Specific Impact of Sex Hormones on the Immune System. Int J Mol Sci. 2023; 24 (7): 6302. [DOI:10.3390/ijms24076302]
23. Murgia F, Giagnoni F, Lorefice L, Caria P, Dettori T, D'Alterio MN, et al. Sex Hormones as Key Modulators of the Immune Response in Multiple Sclerosis: A Review. Biomedicines. 2022; 10 (12): 3107. [DOI:10.3390/biomedicines10123107]
24. Taslem Mourosi J, Anwar S, Hosen MJ. The sex and gender dimensions of COVID-19: A narrative review of the potential underlying factors. Infect Genet Evol. 2022; 103:105338. [DOI:10.1016/j.meegid.2022.105338]
25. Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020; 116 (14): 2197-2206. [DOI:10.1093/cvr/cvaa284]
26. Patil A, Tripathy JP, Deshmukh V, Sontakke B, Tripathi SC. Sex hormones and COVID-19: tussle between the two. Monaldi Arch Chest Dis. 2020; 90 (4). [DOI:10.4081/monaldi.2020.1461]
27. Busse PJ, Mathur SK. Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol. 2010; 126 (4): 690-9 [DOI:10.1016/j.jaci.2010.08.011]
28. Stiasny K, Aberle JH, Keller M, Grubeck-Loebenstein B, Heinz FX. Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis. PLoS One. 2012; 7 (3): e34145. [DOI:10.1371/journal.pone.0034145]
29. Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol. 202; 11: 571416. [DOI:10.3389/fphys.2020.571416]
30. Grifoni A, Alonzi T, Alter G, Noonan DM, Landay AL, Albini A, et al. Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis. Front Immunol. 2023; 14: 1146704. [DOI:10.3389/fimmu.2023.1146704]
31. van den Berg JM, Remmelzwaal S, Blom MT, van Hoek BACE, Swart KMA, Overbeek JA, et al. Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review. Vaccines (Basel). 2022; 11 (1): 24. [DOI:10.3390/vaccines11010024]
32. He YF, Ouyang J, Hu XD, Wu N, Jiang ZG, Bian N, et al. Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review. World J Diabetes. 2023; 14 (6): 892-918. [DOI:10.4239/wjd.v14.i6.892]
33. Kusunoki H, Ekawa K, Ekawa M, Kato N, Yamasaki K, Motone M, Shimizu H. Trends in Antibody Titers after SARS-CoV-2 Vaccination-Insights from Self-Paid Tests at a General Internal Medicine Clinic. Medicines (Basel). 2023; 10 (4): 27. [DOI:10.3390/medicines10040027]
34. Mochizuki T, Hori T, Yano K, Ikari K, Okazaki K. Factors Associated with Change in SARS-CoV-2 Antibody Titers from Three to Six Months after the Administration of the BNT162b2 mRNA COVID-19 Vaccine among Healthcare Workers in Japan: A Prospective Study. Intern Med. 2022; 61 (8): 1139-43. [DOI:10.2169/internalmedicine.8902-21]
35. Batra N, Acharya S, Ahuja A, Saboo K. Guarding Health: A Comprehensive Review of Nosocomial Infections in Sickle Cell Anemia, a Multifaceted Approach to Prevention. Cureus. 2024; 16 (1): e53224. [DOI:10.7759/cureus.53224]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.